Prevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation.

Eita MiyashitaNozomi SugiharaMiho TanakaHiromi IwasakiMaki Monna-OiwaMasamichi IsobeSeiko KatoSatoshi TakahashiYasuhito NannyaYukari TsuruTakaaki Konuma

Published in: Leukemia & lymphoma (2023)

Keyphrases

stem cell transplantation
risk factors
bone marrow
young adults
hematopoietic stem cell
high dose
adverse drug
low dose